Search
for
Sort by
Research
480-510 / 1000+ resultsresearch Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss
Bicalutamide shows promise for treating female hair loss.
research Anti-androgen therapy for the treatment of female pattern hair loss: a clinical review of current and emerging therapies
Oral and topical anti-androgens can help treat female hair loss, but have side effects.
research Traversing the Pathway and Exploring the Link—A Clinical and Epidemiological Study in Alopecia Areata and Its Association with Autoimmune Diseases
Alopecia areata is significantly linked to thyroid issues and may worsen with diabetes severity.
research No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: a retrospective cohort database study
Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.
research Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX
Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.
research From the Cochrane Library: Interventions for Nail Psoriasis
Systemic therapies improve nail psoriasis but have high side effects; more research is needed.
research Upadacitinib for Alopecia: Current Evidence and Clinical Insights
Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.
research Androgenetic Alopecia is Associated With Increased Risk of Peripheral Venous Disorders in a Large Retrospective Cohort Study
People with androgenetic alopecia may have a higher risk of peripheral venous disorders.
research Low-dose oral minoxidil for androgenetic alopecia is not associated with significant changes in alcohol consumption: a retrospective study of 21,971 patients
Low-dose oral minoxidil does not significantly change alcohol consumption.
research Androgenetic Alopecia Is not Associated With Major Vascular Comorbidities: A Retrospective Case‐Control Study of 8230 Patients
Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.
research Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits
Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.
research Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients
Start low-dose minoxidil gradually, especially for women, to reduce side effects.
research Hair-raising costs: evaluating botulinum toxin treatment for androgenetic alopecia
Botulinum toxin is not effective or cost-efficient for treating male pattern baldness.
research Nail pigmentation may be an early sign of minocycline-associated cutaneous pigmentation: A systematic review
Nail color change might be an early sign of skin pigmentation from minocycline.
research Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.
research Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients
Targeted testing for telogen effluvium patients can save healthcare costs.
research Comprehensive Review of Tinea Capitis in Adults: Epidemiology, Risk Factors, Clinical Presentations, and Management
Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.
research Low-dose oral minoxidil for treatment of androgenetic alopecia: gender differences in blood pressure and hypotension-related adverse effects
research Increased Interest in Oral Minoxidil for Hair Loss Treatment Following Publication of August 2022 New York Times Article: A Google Trends Analysis
Public interest in oral minoxidil for hair loss increased after a New York Times article.
research Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study
Taking a small dose of the hair growth medicine minoxidil by mouth does not really change your blood pressure.
research 41126 Analysis of Nail Excision Practice Patterns in the Medicare Provider Utilization and Payment Database 2012-2017
Podiatrists perform nearly all nail excisions in the US.
research FORMULATION AND EVALUATION OF MINOXIDIL GEL IN COMBINATION WITH ALOE VERA FOR TOPICAL APPLICATION FOR THE TREATMENT OF ALOPECIA
The gel combining minoxidil and Aloe vera could be an effective, non-irritating treatment for hair loss.
research Issue Information
research EMULSION FORMULATION OF CAMELLIA SINENSIS AND ALLIUM CEPA FOR ALOPECIA AREATA
The emulsion made from tea plant and onion extracts shows promise for treating hair loss.
research Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.
research A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.
research Reply to: “Response to ‘Rethinking biotin therapy for hair, nail, and skin disorders’”
Biotin treatment for hair, nail, and skin disorders has weak evidence and should not be recommended unless new research shows clear benefits.
research Contents Vol. 2, 2016
The document discusses various nail and hair disorders and their treatments.